Reply to Wolowich and Kwon
- PMID: 32613227
- PMCID: PMC8096210
- DOI: 10.1093/cid/ciaa911
Reply to Wolowich and Kwon
Comment in
-
Simulation of Drug in the Lung Can Be Misleading.Clin Infect Dis. 2021 May 4;72(9):1677-1678. doi: 10.1093/cid/ciaa907. Clin Infect Dis. 2021. PMID: 32607540 No abstract available.
Comment on
-
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237. Clin Infect Dis. 2020. PMID: 32150618 Free PMC article.
-
Simulation of Drug in the Lung Can Be Misleading.Clin Infect Dis. 2021 May 4;72(9):1677-1678. doi: 10.1093/cid/ciaa907. Clin Infect Dis. 2021. PMID: 32607540 No abstract available.
References
-
- Yao X, Ye F, Zhang M, et al. . In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [manuscript published online ahead of print 9 March 2020]. Clin Infect Dis 2020; 71:732–9. - PMC - PubMed
-
- Mahase E. Hydroxychloroquine for Covid-19: the end of the line? BMJ 2020; 369:m2378. - PubMed
-
- Tsuji A, Yoshikawa T, Nishide K, et al. . Physiologically based pharmacokinetic model for beta-lactam antibiotics I: tissue distribution and elimination in rats. J Pharm Sci 1983; 72:1239–52. - PubMed
